DE69930844D1 - Inhibitoren von mycobakterien - Google Patents

Inhibitoren von mycobakterien

Info

Publication number
DE69930844D1
DE69930844D1 DE69930844T DE69930844T DE69930844D1 DE 69930844 D1 DE69930844 D1 DE 69930844D1 DE 69930844 T DE69930844 T DE 69930844T DE 69930844 T DE69930844 T DE 69930844T DE 69930844 D1 DE69930844 D1 DE 69930844D1
Authority
DE
Germany
Prior art keywords
mycobacteria
inhibitors
treatment
certain
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69930844T
Other languages
English (en)
Other versions
DE69930844T2 (de
Inventor
Meenakshi Balganesh
Kantharaj Ethirajulu
Babita Singh Ganguly
Ramachandran Janakiraman
Parvinder Kaur
Rangarao Kajipalya
Santosh Nandan
Ramanujulu Pondi Murugappan
Narayanan Ramamurthy
Balasubramanian Venkataraman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WEY HANS HEINRICH
Original Assignee
WEY HANS HEINRICH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802118A external-priority patent/SE9802118D0/xx
Application filed by WEY HANS HEINRICH filed Critical WEY HANS HEINRICH
Application granted granted Critical
Publication of DE69930844D1 publication Critical patent/DE69930844D1/de
Publication of DE69930844T2 publication Critical patent/DE69930844T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
DE69930844T 1998-05-05 1999-05-03 Inhibitoren von mycobakterien Expired - Fee Related DE69930844T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN969MA1998 1998-05-05
INMA096998 1998-05-05
SE9802118 1998-06-15
SE9802118A SE9802118D0 (sv) 1998-06-15 1998-06-15 Mycobacterial inhibitors
PCT/SE1999/000732 WO1999065483A1 (en) 1998-05-05 1999-05-03 Mycobacterial inhibitors

Publications (2)

Publication Number Publication Date
DE69930844D1 true DE69930844D1 (de) 2006-05-24
DE69930844T2 DE69930844T2 (de) 2006-12-28

Family

ID=26324850

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69930844T Expired - Fee Related DE69930844T2 (de) 1998-05-05 1999-05-03 Inhibitoren von mycobakterien

Country Status (14)

Country Link
US (1) US6476053B1 (de)
EP (1) EP1075261B1 (de)
JP (1) JP2002518324A (de)
KR (1) KR20010043322A (de)
CN (1) CN1201735C (de)
AT (1) ATE322898T1 (de)
AU (1) AU739140B2 (de)
BR (1) BR9910185A (de)
CA (1) CA2330667A1 (de)
DE (1) DE69930844T2 (de)
IL (1) IL139144A0 (de)
NO (1) NO20005548L (de)
NZ (1) NZ507620A (de)
WO (1) WO1999065483A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1864660B1 (de) 2001-11-01 2010-12-29 Spectrum Pharmaceuticals, Inc. Medizinische Zusammensetzungen zur intravesikalen Behandlung von Blasenkrebs
EP1919890A1 (de) * 2005-08-19 2008-05-14 AstraZeneca AB Pyrazolonderivate zur behandlung von tuberkulose
GB0520368D0 (en) * 2005-10-06 2005-11-16 Univ Aston Antibacterial pyrrols
CN102307854B (zh) * 2008-12-04 2014-11-12 巴斯夫欧洲公司 用于制备1，3-和1，4-烷基甲基吡咯烷酮的衣康酸或衣康酸衍生物与伯胺的混合物
KR102401413B1 (ko) * 2015-12-23 2022-05-24 헨켈 아게 운트 코. 카게아아 금속 가공 유체
CN107033060B (zh) * 2017-05-04 2020-01-14 浙江工业大学 一种n-取代顺丁烯二酰亚胺类化合物及其制备与抗菌应用
KR20190065178A (ko) * 2017-12-01 2019-06-11 주식회사 굳티셀 탈모의 예방 또는 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883342A (en) * 1973-04-13 1975-05-13 Akzona Inc Plant growth regulators

Also Published As

Publication number Publication date
AU4304199A (en) 2000-01-05
DE69930844T2 (de) 2006-12-28
ATE322898T1 (de) 2006-04-15
KR20010043322A (ko) 2001-05-25
CN1201735C (zh) 2005-05-18
NO20005548L (no) 2000-12-04
EP1075261A1 (de) 2001-02-14
CN1308532A (zh) 2001-08-15
AU739140B2 (en) 2001-10-04
CA2330667A1 (en) 1999-12-23
US6476053B1 (en) 2002-11-05
NO20005548D0 (no) 2000-11-03
WO1999065483A1 (en) 1999-12-23
BR9910185A (pt) 2001-01-09
EP1075261B1 (de) 2006-04-12
JP2002518324A (ja) 2002-06-25
IL139144A0 (en) 2001-11-25
NZ507620A (en) 2003-05-30

Similar Documents

Publication Publication Date Title
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
ID25853A (id) Penghambat saluran kalium
EA199800667A1 (ru) Новые фенантридины
DE69905170T2 (de) Thiazolopyrimidinderivate
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
TR200200204T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
NO20005224D0 (no) BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse
ATE264863T1 (de) 28-epirapaloge
CY1107531T1 (el) Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
DK0833839T3 (da) Heterocykliske peptidylforbindelser, der er nyttige til behandling af thrombinrelaterede sygdomme
TR200000756T2 (tr) Davranış bozukluğu tedavisi.
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
BR9805544A (pt) Uso de um composto.
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DE60037813D1 (de) Antworten auf hypoxia modifizieren
SE9802937D0 (sv) Novel compounds
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
DK1051187T3 (da) Behandling af follikulære lymfomer ved anvendelse af inhibitorer af lymfotoxin(LT)-syntesevejen
DE69930844D1 (de) Inhibitoren von mycobakterien
IT1306165B1 (it) Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee